Search

Author/Creator Lamers, Daniela

2. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus. Issue 3 (28th November 2018)

Authors:
Hövelmann, Ulrike; Olsen, Minna Brændholt; Mouritzen, Ulrik; Lamers, Daniela; Kronshage, Birgit; Heise, Tim
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 3(2019)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906. Issue 4 (30th January 2023)

Authors:
Jungnik, Arvid; Arrubla Martinez, Jorge; Plum‐Mörschel, Leona; Kapitza, Christoph; Lamers, Daniela; Thamer, Claus; Schölch, Corinna; Desch, Michael; Hennige, Anita M.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 4(2023)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes. Issue 11 (12th July 2018)

Authors:
Andersen, Grit; Meiffren, Grégory; Lamers, Daniela; DeVries, J. Hans; Ranson, Aymeric; Seroussi, Cyril; Alluis, Bertrand; Gaudier, Martin; Soula, Olivier; Heise, Tim
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 20:Issue 11(2018)
Page Start:
2627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗